SAVIENT PHARMACEUTICALS INC (SVNT) has 71 open-market insider trades by 20 insiders since 2006. The most active filer is Herbert J. Conrad, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Zebulun D. Horowitz | SVP - Chief Medical Officer | — | 6 | $1.7M | 2009-02-17 |
| Herbert J. Conrad | Dir | — | 9 | $1.6M | 2010-06-08 |
| Christopher G. Clement | — | — | 5 | $1.3M | 2009-12-09 |
| Brian J. Hayden | — | — | 6 | $1.0M | 2009-02-17 |
| Robert Lamm | — | — | 7 | $787K | 2009-02-17 |
| Philip K. Yachmetz | Pres | — | 5 | $756K | 2013-10-15 |
| Joseph Klein III | Dir | — | 5 | $574K | 2010-06-08 |
| Paul Hamelin | Pres | — | 8 | $517K | 2011-02-14 |
| David Gionco | Chief Accounting Officer | — | 2 | $291K | 2013-10-15 |
| John Johnson | CEO | — | 3 | $151K | 2012-01-03 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Virgil Thompson | Director | Sell | $2K | 2013-12-04 |
| Director | Sell | $2K | 2013-10-17 | |
| Ginger Constantine | Director | Sell | $616 | 2013-10-16 |
| Richard Crowley | President | Sell | $9K | 2013-10-15 |
| Philip K. Yachmetz | President | Sell | $21K | 2013-10-15 |
| David Gionco | Chief Accounting Officer | Sell | $4K | 2013-10-15 |
Companies that share insiders with SVNT, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| John Hamill | President | Sell | $3K | 2013-10-15 |
| Kenneth Bahrt | SVP & Chief Medical Officer | Sell | $6K | 2013-10-15 |
| Louis Ferrari | President | Sell | $581 | 2013-05-22 |
| Kenneth Bahrt | SVP & Chief Medical Officer | Sell | $925 | 2013-04-30 |
| Richard Crowley | COO & EVP | Sell | $2K | 2013-04-30 |
| David Gionco | Group VP & Chief Acct. Officer | Sell | $1K | 2013-03-06 |
| Louis Ferrari | President | Sell | $371 | 2013-02-25 |
| Richard Crowley | EVP & Biopharmaceutical Ops | Sell | $51K | 2013-02-04 |
| Kenneth Bahrt | SVP & Chief Medical Officer | Sell | $30K | 2013-02-04 |